Strengthening HIV prevention among most-at-risk populations (MARPs) in the Syrian Arab Republic:
DHS Working Papers No. 119
Ce document a été élaboré par Peter Ventevogel, consultant, sous la supervision de Marian Schilperoord. Les versions préliminaires de cette publication ont grandement bénéficié de la contribution de plusieurs personnes au sein de l’UNHCR et d’organisations partenaires. Nous voudrions tou...t particulièrement remercier les collègues suivants pour leur relecture du document : A l’UNHCR: Gregory Garras, Sarah Harrison, Alexandra Kaun, Stefanie Krause, Preeta Law, Allen Gidraf Kahindo Maina, MaryBeth Morand, Audrey Nirrengarten, Martina Nicole Pomeroy, Monika Sandvik-Nylund, Ita Sheehy, Paul Spiegel, Margriet Veenma and Constanze Quosh. Dans les autres organisations: Carolina Echeverri (consultante SMSPS) Sabine Rakotomalala (UNICEF), Emmanuel Streel (consultant SMSPS), Wietse Tol (Université Johns Hopkins) Mark van Ommeren (OMS) et Inka Weissbecker (International Medical Corps).
more
An Easy-Reference Guidebook for Healthcare Providers In Developed and Developing Countries
Services, Identified needs and recommendations following the April and May 2015 Earthquakes in Nepal
Attention-Deficit/Hyperactivity Disorder
This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions
expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to
describe the best treatments and pra...ctices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws of their country of practice. Some medications may not be available in some countries and readers should consult the specific drug information since not all dosages and unwanted effects are mentioned. Organizations, publications and websites are cited or linked to illustrate issues or as a source of further information. This does not mean that authors, the Editor or IACAPAP endorse their content or recommendations, which should be critically assessed by the reader. Websites may also change or cease to exist.
more
In this report, potential reasons for this apparent
contradiction between cherished human values
and observed social actions are explored with a
view to better formulating concrete steps that
governments and other stakeholders can take to
reshape social attitudes and public policy.
Mental disorders are one of the top public health challenges in the WHO European Region, affecting about 25% of the population every year. In all countries, mental health problems are much more prevalent among the people who are most deprived. The WHO European Region therefore faces diverse challeng...es affecting both the mental well-being of the population and the provision and quality of care for people with mental health problems.
The European Mental Health Action Plan focuses on seven interlinked objectives and proposes effective action to strengthen mental health and well-being. Investing in mental health is essential for the sustainability of health and socioeconomic policies in the European Region. The Action Plan corresponds to the four priority areas of the European policy framework for health and wellbeing, Health 2020, and will contribute directly to its implementation.
more
WHO clinical and policy guidelines
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety and efficacy of “re-purposed” drugs that have been widely used to treat other infections but are al...so showing promise in the treatment of DR-TB, including linezolid and clofazimine. This special supplemental guide has been developed for nurses, because it is essential that nurses be provided with material that maximizes their ability to provide optimal support to patients who are receiving new and re-purposed drugs
more
From raising awareness to building capacity
Meeting Report
World Health Organization, Geneva, Switzerland 16 -18 September 2013
Revided Version
September 2013